Benzinga | May 25, 2021 08:35AM EDT

Avinger Announces Issuance And Allowance Of Seven US Patents

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the issuance and allowance of seven U.S. patents to date in 2021.